Inventor
GARNER WILLIAM J
US17 patents
⚠️ This page may combine multiple inventors who share the name “GARNER WILLIAM J”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
LUCENT TECHNOLOGIES INC
8 patentsUS5890056AMar 30, 1999
Channel usage monitoring arrangement for base station
LUCENT TECHNOLOGIES INC37 citations92
US5963170AOct 5, 1999
Fixed dual frequency band antenna
LUCENT TECHNOLOGIES INC21 citations91
US5717409AFeb 10, 1998
Dual frequency band antenna system
LUCENT TECHNOLOGIES INC30 citations91
US5974302AOct 26, 1999
Dual band cellular/PCS transceiver
LUCENT TECHNOLOGIES INC18 citations80
US6181951B1Jan 30, 2001
Mobile telephony standards converter
LUCENT TECHNOLOGIES INC6 citations72
US6052030AApr 18, 2000
Low voltage variable gain amplifier with feedback
LUCENT TECHNOLOGIES INC12 citations72
US6035192AMar 7, 2000
Mobile telephony standards converter
LUCENT TECHNOLOGIES INC4 citations61
US6334055B1Dec 25, 2001
Mobile telephony standards converter
LUCENT TECHNOLOGIES INC1 citations51
RACE ONCOLOGY LTD
5 patentsUS10548876B2Feb 4, 2020
Compositions to improve the therapeutic benefit of bisantrene and analogs and derivatives thereof
RACE ONCOLOGY LTD3 citations70
US10500192B2Dec 10, 2019
Combinatorial methods to improve the therapeutic benefit of bisantrene and analogs and derivatives thereof
RACE ONCOLOGY LTD1 citations70
US9993460B2Jun 12, 2018
Compositions to improve the therapeutic benefit of bisantrene and analogs and derivatives thereof
RACE ONCOLOGY LTD3 citations70
US11135201B2Oct 5, 2021
Compositions to improve the therapeutic benefit of bisantrene and analogs and derivatives thereof
RACE ONCOLOGY LTD0 citations59
US11147800B2Oct 19, 2021
Combinatorial methods to improve the therapeutic benefit of bisantrene and analogs and derivatives thereof
RACE ONCOLOGY LTD0 citations55
DELMAR PHARMACEUTICALS INC
2 patentsUS9814693B2Nov 14, 2017
Veterinary use of dianhydrogalactitol, diacetyldianhydrogalactitol, and dibromodulcitol to treat malignancies
DELMAR PHARMACEUTICALS INC2 citations70
US11026914B2Jun 8, 2021
Use of dianhydrogalactitol and analogs and derivatives thereof to treat recurrent malignant glioma or progressive secondary brain tumor
DELMAR PHARMACEUTICALS INC1 citations51